Skip to main content
Caplight Logo









Faceland

Faceland

Private
Schiphol-RijkHealthcare & Life Scienceshttps://facelandclinic.com/nl

Last Round

Buyout/LBO

Nov 1, 2023

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Faceland operates in Healthcare & Life Sciences and is based in Schiphol-Rijk. It was founded in 2013.

Faceland is a medical aesthetics company that operates a chain of clinics providing injectable treatments and cosmetic surgery services.

Sector

Healthcare & Life Sciences

Verticals

Fashion & Beauty, D2C Brands

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Faceland Comparables

Compare Faceland with similar companies based on industry and business-model similarity.

Faceland comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Body Clinic
92%
Docboom GmbH
87%
Sisu Aesthetic Clinic
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Faceland Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBONov 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Mathijs De Lange

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Faceland Investors

Notable investors and investment history

Faceland investors
InvestorRounds
VerlinvestBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open roles increased to 232, 3x the trailing average.

  • Sep 21, 2026

    Open roles increased to 86, representing 43% of headcount.

Book a demo to see all signals

For institutional investors. Book with your work email.

Faceland Filings

Explore SEC and related filing metadata, where available.

Faceland filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Faceland's valuation, stock price, and market status.

Is Faceland a public or private company?

Faceland is a private company.

What is the current stock price of Faceland?

Faceland is a private company, so its shares have no public market price. Caplight tracks Faceland's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Faceland worth (valuation)?

Valuation information for Faceland is not publicly available.

Can I buy Faceland stock?

Faceland shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Faceland's last funding round?

Faceland's most recent funding round was Buyout/LBO on November 1, 2023.

Who are the main investors in Faceland?

Key investors in Faceland include Verlinvest.

Will Faceland IPO soon?

No public IPO plans have been announced for Faceland.

How can I track Faceland secondary market activity?

Caplight tracks bids, offers, and trades in Faceland's shares on secondary markets.

Firmographic Details

HeadquartersSchiphol-Rijk
Employee Range201
Year Founded2013
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?